PortalPublikationenPSOLAR: design, utility, and preliminary results of a prospe...

PSOLAR: design, utility, and preliminary results of a prospective, international, disease-based registry of patients with psoriasis who are receiving, or are candidates for, conventional systemic treatments or biologic agents.

Standard

PSOLAR: design, utility, and preliminary results of a prospective, international, disease-based registry of patients with psoriasis who are receiving, or are candidates for, conventional systemic treatments or biologic agents. / Papp, Kim A; Strober, Bruce; Augustin, Matthias; Calabro, Steve; Londhe, Anil; Chevrier, Marc; Investigators, PSOLAR; Committee, Steering.

in: J DRUGS DERMATOL, Jahrgang 11, Nr. 10, 10, 2012, S. 1210-1217.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Papp, KA, Strober, B, Augustin, M, Calabro, S, Londhe, A, Chevrier, M, Investigators, PSOLAR & Committee, S 2012, 'PSOLAR: design, utility, and preliminary results of a prospective, international, disease-based registry of patients with psoriasis who are receiving, or are candidates for, conventional systemic treatments or biologic agents.', J DRUGS DERMATOL, Jg. 11, Nr. 10, 10, S. 1210-1217. <http://www.ncbi.nlm.nih.gov/pubmed/23134986?dopt=Citation>

APA

Papp, K. A., Strober, B., Augustin, M., Calabro, S., Londhe, A., Chevrier, M., Investigators, PSOLAR., & Committee, S. (2012). PSOLAR: design, utility, and preliminary results of a prospective, international, disease-based registry of patients with psoriasis who are receiving, or are candidates for, conventional systemic treatments or biologic agents. J DRUGS DERMATOL, 11(10), 1210-1217. [10]. http://www.ncbi.nlm.nih.gov/pubmed/23134986?dopt=Citation

Vancouver

Papp KA, Strober B, Augustin M, Calabro S, Londhe A, Chevrier M et al. PSOLAR: design, utility, and preliminary results of a prospective, international, disease-based registry of patients with psoriasis who are receiving, or are candidates for, conventional systemic treatments or biologic agents. J DRUGS DERMATOL. 2012;11(10):1210-1217. 10.

Bibtex

@article{6b2068abefea40768a253d785044b206,
title = "PSOLAR: design, utility, and preliminary results of a prospective, international, disease-based registry of patients with psoriasis who are receiving, or are candidates for, conventional systemic treatments or biologic agents.",
abstract = "Long-term observational studies can better characterize the impact of systemic agents on psoriasis.",
keywords = "Adult, Humans, Male, Female, Middle Aged, Prospective Studies, Body Mass Index, Data Interpretation, Statistical, Body Surface Area, *Registries, Obesity/complications, Antibodies, Monoclonal/*adverse effects/therapeutic use, Arthritis, Psoriatic/complications, Cardiovascular Diseases/complications, Immunologic Factors/*adverse effects/therapeutic use, Phototherapy, *Product Surveillance, Postmarketing, Psoriasis/complications/pathology/*therapy, Adult, Humans, Male, Female, Middle Aged, Prospective Studies, Body Mass Index, Data Interpretation, Statistical, Body Surface Area, *Registries, Obesity/complications, Antibodies, Monoclonal/*adverse effects/therapeutic use, Arthritis, Psoriatic/complications, Cardiovascular Diseases/complications, Immunologic Factors/*adverse effects/therapeutic use, Phototherapy, *Product Surveillance, Postmarketing, Psoriasis/complications/pathology/*therapy",
author = "Papp, {Kim A} and Bruce Strober and Matthias Augustin and Steve Calabro and Anil Londhe and Marc Chevrier and PSOLAR Investigators and Steering Committee",
year = "2012",
language = "English",
volume = "11",
pages = "1210--1217",
journal = "J DRUGS DERMATOL",
issn = "1545-9616",
publisher = "Journal of Drugs in Dermatology",
number = "10",

}

RIS

TY - JOUR

T1 - PSOLAR: design, utility, and preliminary results of a prospective, international, disease-based registry of patients with psoriasis who are receiving, or are candidates for, conventional systemic treatments or biologic agents.

AU - Papp, Kim A

AU - Strober, Bruce

AU - Augustin, Matthias

AU - Calabro, Steve

AU - Londhe, Anil

AU - Chevrier, Marc

AU - Investigators, PSOLAR

AU - Committee, Steering

PY - 2012

Y1 - 2012

N2 - Long-term observational studies can better characterize the impact of systemic agents on psoriasis.

AB - Long-term observational studies can better characterize the impact of systemic agents on psoriasis.

KW - Adult

KW - Humans

KW - Male

KW - Female

KW - Middle Aged

KW - Prospective Studies

KW - Body Mass Index

KW - Data Interpretation, Statistical

KW - Body Surface Area

KW - Registries

KW - Obesity/complications

KW - Antibodies, Monoclonal/adverse effects/therapeutic use

KW - Arthritis, Psoriatic/complications

KW - Cardiovascular Diseases/complications

KW - Immunologic Factors/adverse effects/therapeutic use

KW - Phototherapy

KW - Product Surveillance, Postmarketing

KW - Psoriasis/complications/pathology/therapy

KW - Adult

KW - Humans

KW - Male

KW - Female

KW - Middle Aged

KW - Prospective Studies

KW - Body Mass Index

KW - Data Interpretation, Statistical

KW - Body Surface Area

KW - Registries

KW - Obesity/complications

KW - Antibodies, Monoclonal/adverse effects/therapeutic use

KW - Arthritis, Psoriatic/complications

KW - Cardiovascular Diseases/complications

KW - Immunologic Factors/adverse effects/therapeutic use

KW - Phototherapy

KW - Product Surveillance, Postmarketing

KW - Psoriasis/complications/pathology/therapy

M3 - SCORING: Journal article

VL - 11

SP - 1210

EP - 1217

JO - J DRUGS DERMATOL

JF - J DRUGS DERMATOL

SN - 1545-9616

IS - 10

M1 - 10

ER -